Existing literature only reports a few patients with Noonan syndrome (NS) and Noonan syndrome with multiple lentigines (NSML) who underwent cochlear implantation (CI). The present study describes four NS patients and one NSML patient with a PTPN11 mutation. They all had severe to profound hearing loss, and they received a CI. The age at which the CI surgery occurred ranged from 1-13 years old, and the audiological results in all five patients improved after the CI. Otological and audiological examinations in NS and NSML are important, and for those with severe hearing loss, the CI surgery improved the audiological outcome regardless of age.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pLwpvq
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
New analysis shows that some of these amazing flying beasts were far more formidable than we'd ever thought before... -- Read more on...
-
Publication date: Available online 23 February 2017 Source: Cell Author(s): Zachary Lee Johnson, Jue Chen The multidrug resistance protei...
-
Do you speak NHS?Oh, yes: you don’t get far in the health service without being able to generate a seamless flow of the right words, if only...
-
This cohort study evaluates patients who underwent surgical lip augmentation using the superficial musculoaponeurotic system tissue transfer...
-
Background: Neoadjuvant chemotherapy with methotrexate-vinblastine-doxorubicin-cisplatin (MVAC) is the standard of care for muscle-invasive...
-
Publication date: 1 May 2017 Source: Cancer Letters, Volume 393 Author(s): Yuan Li, Nan Sun, Zhiliang Lu, Shouguo Sun, Jianbing Huang, Zha...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oDLxf6 via IFTTT
-
The government has announced its intention to make sex and relationships education (SRE) statutory in all secondary schools, and to make rel...
-
Abstract Purpose The aim of this study is to evaluate the feasibility of a telehealthcare application for operable lung cancer (OLC) patie...
-
Bristol-Myers Squibb Co Cancer Drug Cost Comes Under Fire In U.K. StockNews.com (blog) NICE noted the evidence that nivolumab can ext...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου